MA Beneficiaries May Be at Disadvantage for Complex Cancer Surgeries
November 21st 2022Patients with Medicare Advantage (MA) were 1.5 times more likely to die within a month of surgical removal of their stomach or liver, and twice as likely to die within a month of oncologic surgery of the pancreas, compared with patients with traditional Medicare.
Read More
New Clinical Guidelines Recommend Finerenone for CKD Associated With T2D
November 21st 2022Updated Kidney Disease: Improving Global Outcomes guidelines and a consensus report with the American Diabetes Association support the use of finerenone in certain patients who have chronic kidney disease (CKD) that may be linked to type 2 diabetes (T2D).
Read More
Covid, flu, and respiratory syncytial virus are overwhelming hospitals across the nation; Pfizer claims its new booster may give protection against new subvariants of the COVID-19 Omicron variant; federal audits reveal overcharges and other payment errors in Medicare Advantage (MA) plans.
Read More
High Burden of AD, Bacterial Skin Infections Seen in Young Urban-Living Indigenous People
November 20th 2022Urban-living Indigenous children and young people in high-income countries reported a higher likelihood of current and severe symptoms of atopic dermatitis (AD) compared with a non-Indigenous population, as well as a higher incidence of bacterial skin infections.
Read More
Dr Tochi Okwuosa: There Is a Great Need for Better CVD Risk Prediction in Cardio-Oncology
November 19th 2022In an interview at this year’s American Heart Association Scientific Sessions meeting in Chicago, Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center, discussed the importance of addressing cardiovascular disease (CVD) prevention in patients with cancer who are undergoing treatment.
Watch
Disease Characteristics Vary Widely Among Patients With CRSwNP or CRSsNP
November 19th 2022The investigators of this new study wanted to more clearly define the patient characteristics of the 2 main types of chronic rhinosinusitis: with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).
Read More
Dr Nancy Reau Covers Alcohol Use Disorder Interventions to Prevent Alcoholic Hepatitis
November 19th 2022As patients come into clinic and receive appropriate follow-up, we can hopefully find ways to mitigate the increase in alcoholic hepatitis, said Nancy Reau, MD, section chief of hepatology at Rush University Medical Center.
Watch
JDRF's Tom Robinson Expands on Policies to Ensure Implementation, Access to Key T1D Interventions
November 19th 2022Get type 1 diabetes (T1D) communities involved in solving the problem and implementing T1D interventions in your country, said Tom Robinson, vice president of global access at JDRF.
Watch
Dr Emeline Aviki: Telehealth Allows Patients a Quick Return to Daily Life
November 19th 2022There is a major role for telehealth in oncology care, not only for its convenience but also for giving clinicians the ability to scale nononcologic visits, explained Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group.
Watch
Dr Jason Ezra Hawkes: Education on Chronic Nature, Subtypes of AD Key in Managing Diverse Patients
November 18th 2022Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, discussed why it is important for dermatologists to educate patients on atopic dermatitis (AD) and keep an open mind on variations in disease presentation by skin color.
Watch
Dr Liz Lightstone Discusses Implications of Current Standard of Care for Lupus Nephritis
November 18th 2022Liz Lightstone, MBBS, PhD, FRCP, professor of renal medicine for the Faculty of Medicine, Imperial College London, spoke on issues regarding the current standard of care for lupus nephritis, including steroid overuse, pregnancy, and dose-related toxicity.
Watch
Some Patients With CAD Experience Sustained Remission After Sutimlimab Discontinuation
November 18th 2022A research letter published in Blood Advances details the first clinical evidence of sustained hematologic remission for cold agglutinin disease (CAD) after sutimlimab treatment discontinuation.
Read More
Cancer diagnoses continue to lag after decreased screening during the pandemic; the Biden administration is avoiding declaring a public health emergency after increases in pediatric respiratory syncytial virus (RSV); US agriculture officials are set to change the federal program that assists low-income pregnant women, infants, and children (WIC) with grocery bills.
Read More
As providers strive to deliver seamless, collaborative, and deeply engaging care, advances focused on treating the whole health of a person, wherever they are in their care journey, will be necessary as the health care system continues to evolve to meet the needs of patients and providers alike.
Read More
CAR T-Cell Therapy Can Work as Salvage Treatment in Relapsed MM Following BCMA-Directed CAR T
November 18th 2022New data show patients treated with chimeric antigen receptor (CAR) T-cell therapy as salvage therapy tended to have meaningful results despite treatment failure following B-cell maturation antigen (BCMA) CAR T.
Read More